Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort

被引:8
作者
Gong, Dengmei [1 ]
Adomako-Bonsu, Amma G. [2 ]
Wang, Maijian [3 ]
Li, Jida [1 ]
机构
[1] Zunyi Med Univ, Coll Publ Hlth, Inst Zoonosis, Zunyi, Guizhou, Peoples R China
[2] Univ Med Sch Schleswig Holstein, Inst Toxicol & Pharmacol, Kiel, Germany
[3] Zunyi Med Univ, Affiliate Hosp, Gastrointestinal Surg, Zunyi, Guizhou, Peoples R China
来源
PEERJ | 2023年 / 11卷
关键词
Gut microbiota; Enterotoxigenic Bacteroides fragilis; Genotoxic Escherichia coli; Fusobacterium nucleatum; COLON-TUMOR GROWTH; GERM-FREE RATS; FUSOBACTERIUM-NUCLEATUM; MICROBIOTA; TOXIN; CARCINOGENESIS; CELLS; 1,2-DIMETHYLHYDRAZINE; INFLAMMATION; PROGRESSION;
D O I
10.7717/peerj.15777
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Colorectal cancer (CRC), which develops from the gradual evolution of tubular adenomas and serrated polyps in the colon and rectum, has a poor prognosis and a high mortality rate. In addition to genetics, lifestyle, and chronic diseases, intestinal integrity and microbiota (which facilitate digestion, metabolism, and immune regulation) could promote CRC development. For example, enterotoxigenic Bacteroides fragilis, genotoxic Escherichia coli (pks+ E. coli), and Fusobacterium nucleatum, members of the intestinal microbiota, are highly correlated in CRC. This review describes the roles and mechanisms of these three bacteria in CRC development. Their interaction during CRC initiation and progression has also been proposed. Our view is that in the precancerous stage of colorectal cancer, ETBF causes inflammation, leading to potential changes in intestinal ecology that may provide the basic conditions for pks+ E. coli colonization and induction of oncogenic mutations, when cancerous intestinal epithelial cells can further recruit F. nucleatum to colonise the lesion site and F. nucleatum may contribute to CRC advancement by primarily the development of cancer cells, stemization, and proliferation, which could create new and tailored preventive, screening and therapeutic interventions. However, there is the most dominant microbiota in each stage of CRC development, not neglecting the possibility that two or even all three bacteria could be engaged at any stage of the disease. The relationship between the associated gut microbiota and CRC development may provide important information for therapeutic strategies to assess the potential use of the associated gut microbiota in CRC studies, antibiotic therapy, and prevention strategies.
引用
收藏
页数:26
相关论文
共 142 条
[41]   Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer [J].
Hibner, Grzegorz ;
Kimsa-Furdzik, Malgorzata ;
Francuz, Tomasz .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
[42]   Immunological Mechanisms in Inflammation-Associated Colon Carcinogenesis [J].
Hirano, Takehiro ;
Hirayama, Daisuke ;
Wagatsuma, Kohei ;
Yamakawa, Tsukasa ;
Yokoyama, Yoshihiro ;
Nakase, Hiroshi .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
[43]   F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer [J].
Hong, Jie ;
Guo, Fangfang ;
Lu, Shi-Yuan ;
Shen, Chaoqin ;
Ma, Dan ;
Zhang, Xinyu ;
Xie, Yile ;
Yan, Tingting ;
Yu, TaChung ;
Sun, Tiantian ;
Qian, Yun ;
Zhong, Ming ;
Chen, Jinxian ;
Peng, Yanshen ;
Wang, Cheng ;
Zhou, Xiang ;
Liu, Jianjun ;
Liu, Qiang ;
Ma, Xiong ;
Chen, Ying-Xuan ;
Chen, Haoyan ;
Fang, Jing-Yuan .
GUT, 2021, 70 (11) :2123-2137
[44]   Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells [J].
Iftekhar, Amina ;
Berger, Hilmar ;
Bouznad, Nassim ;
Heuberger, Julian ;
Boccellato, Francesco ;
Dobrindt, Ulrich ;
Hermeking, Heiko ;
Sigal, Michael ;
Meyer, Thomas F. .
NATURE COMMUNICATIONS, 2021, 12 (01)
[45]   Association of Escherichia coli containing polyketide synthase in the gut microbiota with colorectal neoplasia in Japan [J].
Iwasaki, Motoki ;
Kanehara, Rieko ;
Yamaji, Taiki ;
Katagiri, Ryoko ;
Mutoh, Michihiro ;
Tsunematsu, Yuta ;
Sato, Michio ;
Watanabe, Kenji ;
Hosomi, Koji ;
Kakugawa, Yasuo ;
Ikematsu, Hiroaki ;
Hotta, Kinichi ;
Kunisawa, Jun ;
Wakabayashi, Keiji ;
Matsuda, Takahisa .
CANCER SCIENCE, 2022, 113 (01) :277-286
[46]   Host-microbiota maladaptation in colorectal cancer [J].
Janney, Alina ;
Powrie, Fiona ;
Mann, Elizabeth H. .
NATURE, 2020, 585 (7826) :509-517
[47]   Toxigenic and non-toxigenic patterns I, II and III and biofilm-forming ability in Bacteroides fragilis strains isolated from patients diagnosed with colorectal cancer [J].
Jasemi, Seyedesomaye ;
Emaneini, Mohammad ;
Fazeli, Mohammad Sadegh ;
Ahmadinejad, Zahra ;
Nomanpour, Bizhan ;
Heravi, Fatemah Sadeghpour ;
Sechi, Leonardo A. ;
Feizabadi, Mohammad Mehdi .
GUT PATHOGENS, 2020, 12 (01)
[48]   Intestinal Epithelial Cells Exposed to Bacteroides fragilis Enterotoxin Regulate NF-κB Activation and Inflammatory Responses through β-Catenin Expression [J].
Jeon, Jong Ik ;
Ko, Su Hyuk ;
Kim, Jung Mogg .
INFECTION AND IMMUNITY, 2019, 87 (11)
[49]   miR-34a and miR-34b/c Suppress Intestinal Tumorigenesis [J].
Jiang, Longchang ;
Hermeking, Heiko .
CANCER RESEARCH, 2017, 77 (10) :2746-2758
[50]   Repositioning small molecule drugs as allosteric inhibitors of the BFT-3 toxin from enterotoxigenic Bacteroides fragilis [J].
Jimenez-Alesanco, Ana ;
Eckhard, Ulrich ;
del Rio, Marta Asencio ;
Vega, Sonia ;
Guevara, Tibisay ;
Velazquez-Campoy, Adrian ;
Gomis-Ruth, Francesc Xavier ;
Abian, Olga .
PROTEIN SCIENCE, 2022, 31 (10)